Evidence map›Paper›PMID 42550914›Full record

ReviewDiabetes & vascular disease research

The role of ceramides in the pathophysiology of diabetic retinopathy: Mechanisms and Implications for therapeutic strategies.

Xiaoji Niu, Yiwei Huang, Chao Sun, Yan Huo, Kanghua Fu, Shishuang Yu, Tianyuan Wang, Jiajia Liu, Weirong Pu, Jinping Hu and 1 more

Abstract readReview
In one paragraph

Review in Diabetes & vascular disease research. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Xiaoji NiuDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.ORCID 0000-0001-9580-7517
Yiwei HuangDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Chao SunDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Yan HuoDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Kanghua FuDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Shishuang YuDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Tianyuan WangDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Jiajia LiuDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.
Weirong PuDepartment of Endocrinology, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, China.
Jinping HuDepartment of Traditional Chineses Medicine, 363 Hospital, Chengdu, China.ORCID 0009-0004-8910-6254
Liman RenDepartment of Endocrinology, Qinghai Provincial Hospital of Traditional Chinese Medicine, Xining, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Diabetic retinopathy (DR) is a leading cause of vision impairment among individuals with diabetes, driven by microvascular damage and retinal degeneration. Recent evidence implicates ceramides-bioactive sphingolipids-as critical mediators in DR pathogenesis. These lipids influence critical cellular processes, including apoptosis, inflammation, and oxidative stress. Emerging data suggests that ceramide accumulation exacerbates retinal neurodegeneration in DR by modulating key molecular pathways. This review synthesizes current knowledge on the role of ceramides in DR development and progression, examines the factors influencing their activity, and explores the therapeutic potential of targeting ceramide metabolism. By integrating recent findings, this article aims to provide insights for future research and clinical strategies in DR management.

Indexed as

CeramidesDiabetic RetinopathyRetinaAnimalsApoptosisHumansOxidative StressSignal TransductionCeramidesceramidesdiabetic retinopathypathogenesistherapeutic targets

Identifiers

PMID42550914
PMCPMC13438255

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.